857480-35-4

Basic information

• Product Name: 5-(3-bromophenyl)pentanoic acid
• Synonyms: 5-(3-bromophenyl)pentanoic acid
• CAS NO: 857480-35-4
• Molecular Formula: C₁₁H₁₃BrO₂
• Molecular Weight: 257.12372
• Mol File: 857480-35-4.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 86 °C(Press: 27 Torr)
• Appearance: /
• Density: 1.408±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 4.74±0.10(Predicted)
• CAS DataBase Reference: 5-(3-bromophenyl)pentanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(3-bromophenyl)pentanoic acid(857480-35-4)
• EPA Substance Registry System: 5-(3-bromophenyl)pentanoic acid(857480-35-4)

Safety Data

• Hazardous Substances Data: 857480-35-4(Hazardous Substances Data)

Usage

General Description

5-(3-bromophenyl)pentanoic acid is a chemical compound with the molecular formula C11H13BrO2. It is an organic compound that belongs to the class of aromatic carboxylic acids. The structure of the compound includes a pentanoic acid backbone with a phenyl group substituted with a bromine atom at the 3-position. 5-(3-bromophenyl)pentanoic acid may find applications in the pharmaceutical industry as a building block for the synthesis of various drug molecules or as a reagent in organic chemical reactions. It may also have potential uses in medicinal chemistry and drug discovery research.

Upstream product

• 1180670-58-9 (4E)-5-(3-bromophenyl)pent-4-enoic acid 
• 17857-14-6 (3-carboxypropyl)(triphenyl)phosphonium bromide 
• 870679-57-5 5-(3-bromophenyl)pent-4-enoic acid 

Downstream Products

• 1798792-42-3 2-bromo-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-amine 
• 870679-50-8 ethyl 12-bromo-3-(2,4-dichlorophenyl)-3,4-diazatricyclo[8.4.0.0^2,6]tetradeca-1⁽¹⁴⁾,2⁽⁶⁾,4,10,12-pentaene-5-carboxylate 
• 870679-46-2 8-bromo-1-(2',4'-dichlorophenyl)-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxylic acid 

Relevant articles and documents

Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis

Multiple Sclerosis is a chronic autoimmune neurodegenerative disorder of the central nervous system (CNS) that is characterized by inflammation, demyelination, and axonal injury leading to permeant disability. In the early stage of MS, inflammation is the

BENZOAZEPINE ANALOGS AS INHIBITING AGENTS FOR BRUTON'S TYROSINE KINASE

Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their production and compounds of formula (I) for use in treating a disease responsive to the inhibition of Bruton's tyrosine.

BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.